openPR Logo
Press release

Advancing Pharmaceutical Quality and Regulatory Compliance with Gatifloxacin Impurity 2: Essential Reference Standard for Accurate Analysis, Method Validation, and Impurity Profiling in Gatifloxacin-Based Drug Development and Quality Control

07-21-2025 04:27 PM CET | Health & Medicine

Press release from: Aquigen Bio Sciences

Advancing Pharmaceutical Quality and Regulatory Compliance

In the ever-evolving landscape of pharmaceutical research, the accuracy of analytical results is paramount-especially when it comes to antibiotic safety. That's why Aquigen Bio has developed high-quality impurity standards for Gatifloxacin, empowering chemists and quality‐control experts to meet the highest regulatory demands worldwide.

One standout in their catalog is Gatifloxacin Impurity 2.
https://aquigenbio.com/product/gatifloxacin-impurity-2/

Though not used therapeutically, this reference standard plays a critical role in:

Quantifying and qualifying impurities in Gatifloxacin formulations
Supporting stability studies to ensure shelf‐life and consistency
Validating analytical workflows such as HPLC or LC‐MS/MS
Fulfilling regulatory requirements (ICH, USP, EP) for product safety

With complete characterization data and worldwide delivery, this standard is optimized for pharmaceutical labs and regulatory submissions.

Full Suite: Gatifloxacin Impurity 1 & Impurity 3
Aquigen Bio bolsters its offering with additional reference materials:
1. Gatifloxacin Impurity 1
https://aquigenbio.com/product/gatifloxacin-impurity-1/

CAS: 1335198‐95‐2
Formula: C19H22FN3O5
Molecular weight 391.4 amu

Ideal for method validation, this impurity standard supports routine QC and ensures traceability to pharmacopoeial benchmarks.

2. Gatifloxacin Impurity 3
https://aquigenbio.com/product/gatifloxacin-impurity-3/

A further degradation product critical for stress testing
Enables broad-spectrum impurity profiling, ensuring no blind spots in your analytical platform

With these standards, labs can cover a wider range of analytical scenarios-from early-stage R&D to full-scale validation.

Why Impurities Matter in Antibiotics
In antibiotic production, even trace-level impurities can:

Impact patient safety or efficacy
Lead to unexpected stability issues
Trigger scrutiny from regulatory authorities

By adopting multiple impurity standards-Impurity 1, Impurity 2, Impurity 3-scientists enhance detection coverage. This means:
Confidently identifying degradation products
Robustly validating analytical methods
Meeting impurity thresholds set by regulators like the FDA and EMA

Simply put, reliable reference standards form the cornerstone of quality assurance.

What Makes Aquigen Bio's Standards Shine?
Aquigen Bio stands out through:
Comprehensive characterization - Each standard is accompanied by detailed analytical data (COA, spectra).
High purity & performance - Certified traceability to USP/EP standards

Global availability - Sun‐setting geographies and supply chain delays are no longer a worry.

Full analytical support - From API & intermediates to impurity standards, Aquigen covers it all.

Scientists gain access to quality materials, supported by expert technical documentation and global logistics.

Integrated Solution: Full Gatifloxacin Impurities Category
Explore the full range of standards-including Impurities 1, 2, 3, and more-in the dedicated Gatifloxacin impurity standards category at Aquigen:

View Full Category - https://aquigenbio.com/products/impurity-standards/gatifloxacin

This category consolidates multiple impurities, making it easy to source necessary standards in one curated package-or customize your selection based on your program.

Applications & Use Cases
Here's why pharmaceutical labs rely on these standards:
1. Analytical Method Development & Validation
Designing precise HPLC or LC‐MS/MS assays requires true-to-structure references. Impurity 2 is essential in setting detection limits and calibration curves.
2. Stability & Stress‐Testing
By comparing real-world impurities to known standards like Impurity 2 and Impurity 3, formulators can confidently assign peaks and assess degradation pathways.
3. Regulatory Compliance
Impurity profiling forms a backbone of applications such as NDAs and ANDAs. Defined standards ensure demonstrated control over impurity levels.
4. API Manufacturing & Process Control
Suppliers and producers can use Impurity 1 and 2 to optimize purification steps-pinpointing specific byproducts and improving synthetic efficiency.

Spotlight: Understanding Impurity Profiles
Impurity profiling categorizes contaminants as:
Degradation-related: Arise during storage, moisture exposure, heat
Process‐related: Resulting from incomplete synthesis or side‐reactions
Cross‐contaminants: From solvents, intermediates, or equipment

Using Impurity 1, labs monitor process cleanliness. Impurity 2-often a degradation marker-checks product stability. Impurity 3 helps uncover stress-induced artifacts. Together, they provide a comprehensive safety net.

Why You Should Choose Aquigen Bio's Impurity Portfolio

Trustworthy Data: Complete COAs and traceability
Well‐characterized Standards: Molecular identity confirmed
Global Reach: Fast dispatch; worldwide shipping
Simplified Purchasing: Category page unifies product access
Exceptional Support: Backed by scientific consultation

Getting Started: How to Integrate These Standards
Identify needs - Match impurities (1, 2, 3) to analytical or regulatory requirements
Request samples - Use "Quick Enquiry" on each product page
Download COA/SDS - Access full documentation ahead of order
Validate in-lab - Spike reference impurities to test method separation
Implement and Report - Record impurity levels confidently in submission dossiers

In Summary
When it comes to antibiotic quality-especially with agents like Gatifloxacin-accurate impurity profiling isn't optional; it's essential. Aquigen Bio's suite of impurity standards (Impurity 1, 2, 3) empowers analytical teams to:

Confidently validate methods
Monitor stability and process consistency
Meet or exceed global regulatory benchmarks

Contact:
Aquigen Bio Sciences
281/1, Plot No 41,
Hinjawadi - Pirangut Rd,
Kasar Amboli, Pirangut,
Pune, Maharashtra 412108
Phone: +91 7030123794
Email: bd@aquigenbio.com
Visit: www.aquigenbio.com

About Aquigen Bio
Aquigen Bio is an industry-leading supplier of API impurities, reference standards, and custom synthesis solutions. With global logistics, rigorous compliance, and trusted materials, they serve innovators from early-stage R&D to commercial release.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Advancing Pharmaceutical Quality and Regulatory Compliance with Gatifloxacin Impurity 2: Essential Reference Standard for Accurate Analysis, Method Validation, and Impurity Profiling in Gatifloxacin-Based Drug Development and Quality Control here

News-ID: 4111922 • Views:

More Releases from Aquigen Bio Sciences

Aquigen Bio Expands its Impurity Standards Portfolio with Malathion & Dithiodisuccinate Reference Materials
Aquigen Bio Expands its Impurity Standards Portfolio with Malathion & Dithiodisu …
Aquigen Bio Sciences, a leading pharmaceutical impurity‐standards manufacturer based in India, continues to broaden its catalog with new high‐quality analytical reference standards. These include Malathion EP Impurity A, O,O‐Dimethyl Malathion, and Tetraethyl Dithiodisuccinate, designed to support rigorous research, validation, and regulatory compliance in agrochemical and pharmaceutical analysis. Introducing New Additions to the Impurity Standards Line-up https://aquigenbio.com/product/tetraethyl-dithiodisuccinate/ Malathion EP Impurity A This compound-diethyl (2R)-2‐((methoxy(methylthio)phosphoryl)thio)succinate-offers traceability to pharmacopeial standards, such as USP or EP. It is
Aquigen Bio Launches Justicidin Impurity Standards Category to Advance Analytical Excellence in Phytochemical Drug Research
Aquigen Bio Launches Justicidin Impurity Standards Category to Advance Analytica …
Aquigen Bio, a leading global provider of pharmaceutical reference materials and impurity standards, proudly announces the launch of its Justicidin Impurity Standards category-strengthening its commitment to support analytical precision and regulatory compliance in plant-derived compound analysis, especially in oncology, antimicrobial, and ethnopharmacological research. The newly introduced product line includes: Justicidin G https://aquigenbio.com/product/justicidin-g/ Justicidin A https://aquigenbio.com/product/justicidin-a/ Justicidin H https://aquigenbio.com/product/justicidin-h/ Justicidin E https://aquigenbio.com/product/justicidin-e/ These impurity standards are now available under the newly launched Justicidin category: https://aquigenbio.com/products/impurity-standards/justicidin/ Why It Matters: Justicidins
Tizanidine Nitroso Impurity 1 - High-Purity Reference Standard for Reliable Impurity Profiling, Regulatory Compliance, and Safer Tizanidine Drug Development | Aquigen Bio Nitroso Impurity Standards
Tizanidine Nitroso Impurity 1 - High-Purity Reference Standard for Reliable Impu …
In the highly regulated world of pharmaceutical manufacturing, impurity profiling plays a critical role in ensuring drug safety, efficacy, and regulatory compliance. Among the wide range of impurity reference standards required during API development and validation, Tizanidine Nitroso Impurity 1 stands out as a vital compound for researchers and manufacturers working on Tizanidine-based formulations. At Aquigen Bio, we are proud to offer Tizanidine Nitroso Impurity 1, a high-purity reference standard meticulously
Aquigen Bio Launches Comprehensive Josamycin Propionate Impurity Standards Portfolio to Support Pharmaceutical R&D and Regulatory Compliance
Aquigen Bio Launches Comprehensive Josamycin Propionate Impurity Standards Portf …
Aquigen Bio, a leading global provider of pharmaceutical reference materials and impurity standards, proudly announces the launch of its Josamycin Propionate Impurity Standards category, reinforcing its commitment to supporting analytical precision and regulatory compliance in macrolide antibiotic research and production. The newly introduced product line includes: Josamycin Propionate https://aquigenbio.com/product/josamycin-propionate/ Josamycin Propionate EP Impurity A https://aquigenbio.com/product/josamycin-propionate-ep-impurity-a/ Josamycin Propionate EP Impurity B https://aquigenbio.com/product/josamycin-propionate-ep-impurity-b/ These impurity standards are now available under the newly launched Josamycin Propionate category: https://aquigenbio.com/products/impurity-standards/josamycin-propionate/ Why It Matters: Josamycin

All 4 Releases


More Releases for Impurity

Tizanidine Nitroso Impurity 1 - High-Purity Reference Standard for Reliable Impu …
In the highly regulated world of pharmaceutical manufacturing, impurity profiling plays a critical role in ensuring drug safety, efficacy, and regulatory compliance. Among the wide range of impurity reference standards required during API development and validation, Tizanidine Nitroso Impurity 1 stands out as a vital compound for researchers and manufacturers working on Tizanidine-based formulations. At Aquigen Bio, we are proud to offer Tizanidine Nitroso Impurity 1, a high-purity reference standard meticulously
AquigenBio Launches High-Purity EP Impurity Standards for Propylthiouracil, Incl …
AquigenBio is pleased to announce the availability of two essential impurity reference standards-Propylthiouracil EP Impurity A and Propylthiouracil EP Impurity B. These impurity standards are now available to support pharmaceutical companies, contract research organizations, and analytical laboratories engaged in drug development, quality control, and regulatory compliance. Propylthiouracil (PTU) is a well-known antithyroid medication, widely used in the treatment of hyperthyroidism. In line with pharmacopeial guidelines, it is critical to identify and
Precision in Impurity Profiling: Aquigen Bio Introduces High-Purity Doxorubicin …
Pune, India - July 2025 - As regulatory standards tighten across the pharmaceutical industry, the need for accurate, high-purity reference standards has never been more critical. Aquigen Bio, a trusted provider of pharmaceutical reference materials, is proud to announce the availability of Doxorubicin Dimer Impurity 3, a key impurity used in the impurity profiling of the widely used chemotherapeutic agent, Doxorubicin. This launch is part of Aquigen Bio's expanded portfolio of
Breaking Ground in Pharmaceutical Impurity Standards: Aquigen Bio Expands Abirat …
In the evolving landscape of pharmaceutical development and quality control, the identification, synthesis, and supply of high-purity impurity standards play a pivotal role. One of the most significant advancements in recent times is the availability of specialized Abiraterone-related impurity standards-essential tools for characterizing drug formulations and ensuring regulatory compliance. Manufactured and supplied by Aquigen BioSciences, a trusted leader in impurity synthesis and reference standards, these impurity standards offer analytical laboratories and
Unlock Advanced Dabigatran Research with High-Purity Standards: Now Available - …
In the ever-evolving pharmaceutical landscape, precision, safety, and regulatory compliance have never been more crucial. With Dabigatran etexilate mesylate becoming a cornerstone in the management of thromboembolic disorders, the demand for high-purity standards and robust impurity profiling has surged. Recognizing this essential need, a new suite of advanced analytical tools for Dabigatran and its associated impurities has been made available to support the global scientific and quality control community. To kno
Aquigen Bio Expands Oncology Impurity Standards Portfolio with High-Purity Etopo …
India - 07/05/2025 - Aquigen Bio, a leading provider of pharmaceutical impurity reference standards, proudly announces the launch of its latest high-quality product: Etoposide EP Impurity A. This new addition to Aquigen's growing portfolio of oncology-related impurities is tailored to meet the stringent requirements of pharmaceutical manufacturers and analytical laboratories focused on drug safety, efficacy, and compliance. To know more about : Etoposide EP Impurity A https://aquigenbio.com/product/etoposide-ep-impurity-a/ A Strategic Addition to Oncology Drug